CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver

Drug-drug-interactions (DDIs) occur when a drug alters the metabolic rate, efficacy, and toxicity of concurrently used drugs. While almost 1 in 4 adults now use at least 3 concurrent prescription drugs in the United States, the Non-alcoholic fatty liver disease (NAFLD) prevalence has also risen over...

Descripción completa

Detalles Bibliográficos
Autores principales: Rey-Bedon, Camilo, Banik, Peony, Gokaltun, Aslihan, Hofheinz, O., Yarmush, Martin. L., Uygun, M. Korkut, Usta, O. Berk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792443/
https://www.ncbi.nlm.nih.gov/pubmed/35062050
http://dx.doi.org/10.1016/j.biopha.2021.112377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792443/
https://www.ncbi.nlm.nih.gov/pubmed/35062050
http://dx.doi.org/10.1016/j.biopha.2021.112377

Ejemplares similares